Skip to main content

Your search for “Chemotherapy” returned 143 results

Targeting Newly Discovered Pathway Sensitizes Tumors to Radiation and Chemotherapy

September 3, 2015

In some patients, aggressive cancers can become resistant to chemotherapy and radiation treatments. In a paper published in the journal Nature Communications, University of California, San Diego School of Medicine researchers identified a pathway that causes the resistance and a new therapeutic drug that targets this pathway.

Cancer Cells Send Signals Boosting Survival and Drug Resistance in Other Cancer Cells

June 6, 2017

Researchers at University of California San Diego School of Medicine report that cancer cells appear to communicate to other cancer cells, activating an internal mechanism that boosts resistance to common chemotherapies and promotes tumor survival.

Antibody Drug Conjugates May Help Personalize Radiotherapy for Patients with Cancer

October 4, 2016

Many types of cancer become drug resistant, making them difficult to treat. Researchers with University of California San Diego School of Medicine and Moores Cancer Center have identified a strategy to selectively sensitize certain cancer cells to radiation therapy that may improve tumor control and reduce treatment-related side effects.

Clear View of Nanoparticles Helps Researchers Evaluate New Form of Cancer Treatment

February 11, 2016

Clear images of minute packages meant to shield healthy cells from potent anti-cancer drugs have helped researchers evaluate a promising of new approach to chemotherapy.

AI Harnesses Tumor Genetics to Predict Treatment Response

January 18, 2024

Cancer resists treatment in a multitude of ways, but a new algorithm developed by scientists at UC San Diego can decode them all simultaneously.

Combined Chemotherapy and Immunotherapy Shows Promise for Advanced Prostate Cancers

April 29, 2015

…or removing immune-suppressing cells allows a special type of chemotherapy — and the immune cells it activates — to destroy prostate tumors. This novel combination therapy, termed chemoimmunotherapy, achieved near complete remission in mouse models of advanced prostate cancer. The study is published April 29 in Nature.

UC San Diego Health is First in San Diego to offer CAR T-cell Therapy for Some Cancers

December 3, 2018

Following the FDA’s approval of chimeric antigen receptor (CAR) T-cell therapies for the treatment of certain types of non-Hodgkin lymphomas, UC San Diego Health was the first medical center in San Diego to be certified to offer this type of immunotherapy outside of a clinical trial.

New Biomarkers Might Help Personalize Metastatic Colorectal Cancer Treatment

June 17, 2015

…the first line of chemotherapy their doctors recommend. To better predict how patients will respond to chemotherapy drugs before they begin treatment, researchers at University of California, San Diego School of Medicine conducted a proof-of-principle study with a small group of metastatic colorectal cancer patients. The results revealed two genes…

New Biomarker Identifies Colon Cancer Patients Who May Benefit from Chemotherapy

January 20, 2016

…cancer patients who are most likely to benefit from chemotherapy after surgery.

Blocking Neuron Signaling Pathway Could Lead to New Treatments for Peripheral Neuropathy

January 17, 2017

…and rodent models of type 1 and 2 diabetes, chemotherapy-induced neuropathy and HIV.

Category navigation with Social links